Pharmaceutical companies to respond to new medical reform of the compulsory.doc

 PAGE \* MERGEFORMAT 8 Pharmaceutical companies to respond to new medical reform of the compulsory April 6, 2009 afternoon, the new medical reform program came out, a number of basic rules clear, this is what impact pharmaceutical companies, companies that do? Overall, the new medical reform in the pharmaceutical business sales channels (such as proxy mode) It is not good to judge the impact, but the impact of the terminal is now very clear. Pharmaceutical Marketing From EMKT. will undergo a profound transformation, but also bears a very large opportunity. Abolition of drug addition. If you want to cancel the benefits the hospital and sell drugs, but the state can not provide timely relief to this part of the money to the hospital, the hospital sure to find a way, no matter what methods are Pao Bule obtained from the enterprise. What are ways in the end is not yet known, it should be done their best variety, possible ways are: 1, sponsored by a variety of names; 2 requiring companies to inject capital shares of the hospital. Because now a clear public hospital reform encourage social capital to enter, start, poor management of the business began to hospitals and military hospitals; 3 to require pharmaceutical companies to fulfill information for hospital patients in Latin America, or the responsibility of the marketing expert. Essential medicines. Countries to develop a guideline retail price of essential medicines, the provincial government set procurement prices of essential drugs for public bidding and purchasing, uniform distribution, reduce intermediate links, to protect the people’s basic medication. Who pays for who is in charge, the state pays for the necessary strict control Moreover, the right to essential medicines ‘control’ due to strong political will definitely very strict control by the Government’s rent space for small businesses to pay rent. Therefore, we must fight into the directory size, compete on cost, to fight the brand, so only the